Highest return-on-assets companies
Companies ranked by trailing return on assets (ROA) — how efficiently a business turns its asset base into profit. Delayed fundamentals from market data, shown with their as-of date.
Ranked by ROA: companies 2,851–2,875 of 3,067.
| # | Company | Sector | ROA | Net margin | Market cap |
|---|---|---|---|---|---|
| 2851 | Jade Biosciences Inc (JBIO) | Health Care | -36.4% | n/a | $958M |
| 2852 | Kestra Medical Technologies Ltd (KMTS) | Health Care | -36.7% | -138.4% | $1.7B |
| 2853 | Oncology Institute Inc (TOI) | Health Care | -36.8% | -12.1% | $633M |
| 2854 | Lexeo Therapeutics Inc (LXEO) | Health Care | -37.2% | -9063.8% | $237M |
| 2855 | Foghorn Therapeutics Inc (FHTX) | Health Care | -37.5% | -240.3% | $111M |
| 2856 | Ultragenyx Pharmaceutical Inc (RARE) | Health Care | -37.5% | -85.4% | $1.6B |
| 2857 | Dyne Therapeutics Inc (DYN) | Health Care | -37.6% | n/a | $3.4B |
| 2858 | StubHub Holdings Inc Class A (STUB) | Communication Services | -37.7% | -109.2% | $2.3B |
| 2859 | Kura Oncology Inc (KURA) | Health Care | -37.7% | -412.9% | $647M |
| 2860 | Celcuity Inc (CELC) | Health Care | -37.9% | n/a | $3.3B |
| 2861 | Viridian Therapeutics Ors Inc (VRDN) | Health Care | -38.1% | n/a | $3.2B |
| 2862 | Entrada Therapeutics Inc (TRDA) | Health Care | -38.1% | -565.5% | $191M |
| 2863 | Netskope Inc (NTSK) | Information Technology | -38.3% | -95.8% | $8.7B |
| 2864 | Nurix Therapeutics Inc (NRIX) | Health Care | -38.4% | -314.9% | $1.7B |
| 2865 | Perspective Therapeutics Inc (CATX) | Health Care | -38.6% | n/a | $96M |
| 2866 | D-Wave Quantum Inc (QBTS) | Information Technology | -38.8% | -1444.1% | $3.9B |
| 2867 | Cannae Holdings Inc (CNNE) | Financials | -38.9% | -121.2% | $767M |
| 2868 | Teads Holding Co (TEAD) | Communication Services | -38.9% | -39.8% | $18M |
| 2869 | NeoVolta Inc. (NEOV) | Industrials | -40.0% | -161.0% | $154M |
| 2870 | Biodesix Inc (BDSX) | Health Care | -40.3% | -39.8% | $95M |
| 2871 | Aclaris Therapeutics Inc (ACRS) | Health Care | -40.5% | -829.6% | $619M |
| 2872 | Upstream Bio Inc (UPB) | Health Care | -40.5% | -5026.0% | $177M |
| 2873 | Vera Therapeutics Inc Class A (VERA) | Health Care | -40.8% | n/a | $2.2B |
| 2874 | Rhythm Pharmaceuticals Inc (RYTM) | Health Care | -40.9% | -103.6% | $7.8B |
| 2875 | Quantum-Si Inc (QSI) | Health Care | -41.3% | -4160.1% | $291M |
Find more highest return-on-assets companies like these →
Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Every figure is shown with its as-of date on the company page; a company with no data for this metric is excluded from the ranking, never estimated.
Last updated 2026-11-06 — rankings shift as the underlying data refreshes.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.